carfenazine

CAS No. 2622-30-2

carfenazine( —— )

Catalog No. M28924 CAS No. 2622-30-2

carfenazine targets the Dopamine receptor and is used for schizophrenia research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 183 In Stock
10MG 275 In Stock
25MG 471 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    carfenazine
  • Note
    Research use only, not for human use.
  • Brief Description
    carfenazine targets the Dopamine receptor and is used for schizophrenia research.
  • Description
    carfenazine targets the Dopamine receptor and is used for schizophrenia research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Calpain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2622-30-2
  • Formula Weight
    425.59
  • Molecular Formula
    C24H31N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCC(=O)c1ccc2Sc3ccccc3N(CCCN3CCN(CCO)CC3)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lon HK, et al. Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies. Clin Pharmacol Drug Dev. 2019 Apr. 8(3):290.
molnova catalog
related products
  • Abaperidone

    Abaperidone is a potent 5-HT2A receptor and dopamine D2 receptor antagonist with an IC50 of 6.2 for 5-HT2A receptors and 17 nM for dopamine D2 receptors.

  • AHN 1-055 hydrochlor...

    AHN 1-055 hydrochloride is an inhibitor of dopamine transporter (DAT) and dopamine uptake(IC50 = 71 nM).

  • Nomifensine (maleate...

    Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.